| (1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime |
| (2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine |
| (2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; but-2-enedioic acid |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1) |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-pentan-1-one O-(2-aminoethyl) oxime |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl)oxime |
| (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl)oxime maleate |
| (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl)-1-pent |
| (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate |
| (E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate |
| (E)-5-Methoxy-4'-(trifluormethyl)valerophenon-O-(2-aminoethyl)oxim |
| (E)-Fluvoxamine Maleate |
| (Z)-2-butenedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine |
| (Z)-but-2-enedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine |
| (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine |
| 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)- |
| 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1) |
| 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime,(E)-, (Z)-2-butenedioate (1:1) |
| 2-[({(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine (2Z)-but-2-enedioate |
| 2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine |
| 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine |
| 39F183 |
| 5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime |
| 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1) |
| 5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate |
| 54739-18-3 |
| 54739-18-3 (Parent) |
| 54739-20-7 |
| 5LGN83G74V |
| 61718-82-9 |
| 61718-82-9 (maleate) |
| 739F183 |
| 917096-37-8 |
| A830353 |
| A833394 |
| AB0016707 |
| AB00513735_05 |
| AB00513735_06 |
| AB00514702 |
| AB2000054 |
| AC-1679 |
| AC-9541 |
| AC1NT50J |
| AC1Q4JNU |
| AK-51735 |
| AK-51736 |
| AKOS015961142 |
| AKOS016003882 |
| AN-39241 |
| AN-5830 |
| AS-11790 |
| AS-15332 |
| AX8016087 |
| AX8021384 |
| BC226180 |
| BDBM50028091 |
| BG0368 |
| BIDD:GT0609 |
| BPBio1_001199 |
| BRD-K53517854-050-03-2 |
| BSPBio_001089 |
| C07571 |
| C15H21F3N2O2 |
| C15H21F3N2O2.C4H4O4 |
| C19H25F3N2O6 |
| CAS-54739-18-3 |
| CC-28527 |
| CCG-204586 |
| CCG-213494 |
| CHEBI:5138 |
| CHEBI:5139 |
| CHEMBL1409 |
| CHEMBL814 |
| CPD000466268 |
| CS-1839 |
| CS-1840 |
| D00824 |
| D03HFG |
| D07984 |
| D0M5JI |
| Depromel |
| DSSTox_CID_24002 |
| DSSTox_GSID_44002 |
| DSSTox_RID_80097 |
| DTXSID2044002 |
| DTXSID3042558 |
| DU-23000 |
| DU23000 |
| Dumirox |
| Dumyrox |
| EU-0100495 |
| F 2802 |
| F0858 |
| Faverin |
| Fevarin |
| Floxyfral |
| Fluvoxamina |
| Fluvoxamina [INN-Spanish] |
| fluvoxamine |
| Fluvoxamine (INN) |
| Fluvoxamine (maleate) |
| Fluvoxamine [INN:BAN] |
| Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard |
| FLUVOXAMINE MALEATE |
| Fluvoxamine maleate (JP17/USAN) |
| Fluvoxamine maleate [USAN:USP] |
| Fluvoxamine maleate [USAN] |
| Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material |
| Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard |
| Fluvoxamine Maleate, pharmaceutical secondary standard; traceable to USP, PhEur, BP |
| Fluvoxamine maleate, solid |
| Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard |
| fluvoxamine-CR |
| Fluvoxaminum |
| Fluvoxaminum [INN-Latin] |
| FVX |
| HMS1571G11 |
| HMS2098G11 |
| HMS3261D11 |
| HY-B0103 |
| HY-B0103A |
| I01-8382 |
| J90043 |
| KB-209259 |
| KB-209260 |
| Lopac0_000495 |
| LS-101999 |
| LS-102000 |
| Luvox |
| Luvox (TN) |
| Luvox, Floxyfral |
| maleic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine |
| Maveral |
| MK-264 |
| MLS000028469 |
| MLS000758271 |
| MLS001076285 |
| MLS001304717 |
| MLS001401391 |
| MolPort-003-666-870 |
| MolPort-005-943-374 |
| NCGC00018193-04 |
| NCGC00018193-05 |
| NCGC00018193-06 |
| NCGC00018193-07 |
| NCGC00018193-08 |
| NCGC00018193-11 |
| NCGC00021870-04 |
| NCGC00021870-05 |
| NCGC00093897-01 |
| NCGC00093897-02 |
| NCGC00261180-01 |
| NSC 309469 |
| NSC-309469 |
| NSC-759602 |
| NSC309469 |
| NSC759602 |
| O4L1XPO44W |
| O893 |
| Pharmakon1600-01505604 |
| Prestwick2_000995 |
| Prestwick3_000995 |
| s1336 |
| SAM001246977 |
| SCHEMBL33983 |
| SCHEMBL35225 |
| SME 3110 |
| SME-3110 |
| SMR000058449 |
| SMR000466268 |
| SMR000653482 |
| SR-01000075613 |
| SR-01000075613-1 |
| ST24035070 |
| TL8003932 |
| Tox21_110837 |
| Tox21_110837_1 |
| Tox21_500495 |
| UNII-5LGN83G74V |
| UNII-O4L1XPO44W |
| ZINC12466082 |
